If you have been reading about IGF-1 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-07-07. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
=== Manufacturer response === Palm oil, a natural oil extracted from the fruit of oil palm trees that is semi-solid at room temperature (15–25 degrees Celsius), can potentially serve as a substitute for partially hydrogenated fats in baking and processed food applications, although there is disagreement about whether replacing partially hydrogenated fats with palm oil confers any health benefits. A 2006 study supported by the National Institutes of Health and the USDA Agricultural Research Service concluded that palm oil is not a safe substitute for partially hydrogenated fats (trans fats) in the food industry, because palm oil results in adverse changes in the blood concentrations of LDL and apolipoprotein B just as trans fat does. In May 2003, BanTransFats.com Inc., a U.S. non-profit corporation, filed a lawsuit against the food manufacturer Kraft Foods in an attempt to force Kraft to remove trans fats from the Oreo cookie. The lawsuit was withdrawn when Kraft agreed to work on ways to find a substitute for the trans fat in the Oreo. The J.M. Smucker Company, then the American manufacturer of Crisco (the original partially hydrogenated vegetable shortening), in 2004 released a new formulation made from solid saturated palm oil cut with soybean oil and sunflower oil. This blend yielded an equivalent shortening much like the prior partially hydrogenated Crisco, and was labelled zero grams of trans fat per 1 tablespoon serving (as compared with 1.5 grams per tablespoon of original Crisco).
Essential fatty acids (EFAs) are fatty acids that humans and other animals must ingest because the body requires them for good health but cannot synthesize them. Only two fatty acids are known to be essential for humans: alpha-linolenic acid (an omega-3 fatty acid) and linoleic acid (an omega-6 fatty acid).
The reasons for the apparently reduced tolerance development with the preceding psychedelics is unclear. It has been suggested that the lack of tolerance with shorter-acting psychedelics like DMT and DPT might simply be due to their short durations. Contrary to earlier findings, subsequent clinical studies employing DMT by continuous intravenous infusion (also known as DMTx) have found rapid and moderate acute tolerance development. The mechanism of the tolerance with psychedelics is thought to be rapid serotonin 5-HT2A receptor downregulation with very slow recovery. Downstream targets of the serotonin 5-HT2A receptor such as metabotropic glutamate mGlu2 and mGlu3 receptors may also downregulate. It is thought that serotonin 5-HT2A receptors recover to 50% of baseline within 3 to 7 days of the initial psychedelic dose and fully return to baseline within 1 to 4 weeks, with the recovery dependent on the doses and the length of repeated use. Tolerance may limit the effects and potential benefits of psychedelic microdosing, with this having been observed clinically.
Dysprosium perchlorate is an inorganic compound of dysprosium and the perchlorate ion, with the formula Dy(ClO4)3. It is known as an anhydrous salt and in hydrated forms, including the hexahydrate Dy(ClO4)3·6H2O. The anhydrous compound adopts the hexagonal structure characteristic of many rare-earth perchlorates.
=== Lilly's Tempo Pen === Eli Lilly's Tempo system is a diabetes management platform that includes the Tempo Pen, Tempo Smart Button, and the TempoSmart App. The Tempo Pen is a reusable insulin pen that, when paired with the Tempo Smart Button, captures and transmits insulin dose data to the TempoSmart App via Bluetooth. The TempoSmart App can integrate glucose data from compatible devices, such as the Tempo Blood Glucose Meter or Dexcom G7, allowing users to track their insulin doses, glucose levels, and other lifestyle data in one place. The app also includes features such as bolus insulin dose calculation, medication reminders, digital logbooks, trend reports, and diabetes education tools.
Sources: en.wikipedia.org
==== Functions ==== Functions of actin in the nucleus are associated with its ability to polymerize and interact with various ABPs and with structural elements of the nucleus. Nuclear actin is involved in:
=== Physical stability === Micromeritic properties of a particle, i.e. the particle size in a formulation, influence the physical stability of the suspensions and emulsions. The smaller the size of the particle, the better the physical stability of the dosage form owing to the Brownian motion of the particles in the dispersion.
=== Biofilm formation === Pseudomonas syringae produces polysaccharides which allow it to adhere to the surface of plant cells. It also releases quorum sensing molecules, which allows it to sense the presence of other bacterial cells nearby. If these molecules pass a threshold level, the bacteria change their pattern of gene expression to form a biofilm and begin expression of virulence-related genes. The bacteria secrete highly viscous compounds such as polysaccharides and DNA to create a protective environment in which to grow.
=== Media presence === Collins has been a subject of press and tabloid attention since she first began appearing on The Only Way Is Essex in 2011. Her battle with her weight is something that has been widely documented throughout her career, however she has been consistently praised for her confidence, and has promoted body positivity and encouraged women to love themselves no matter what their size. Collins has a large following on social media, having amassed over 2 million followers on Instagram and over 1 million on Twitter. Such is her popularity, she is often paid to promote products and businesses on her pages and can earn up to £75,000 in one day from social media posts. Collins has stated that she only endorses products that she believes in. Collins is widely known for her diva meltdowns and recognisable catchphrases during her appearances on television and in the media, and as a result became the subject of numerous internet memes. She was branded the "meme queen" by the BBC whilst Peter Robinson of The Guardian described her as a "social media powerhouse who has literally made a meme out of mispronouncing the word meme". Collins is a staple of the "hun subculture" and has been regarded as the "Queen of Huns". Her popularity within the LGBT community has seen her make various appearances at nightclubs and events including G-A-Y and Glitterbomb. In June 2023, she performed at the Mighty Hoopla event in Brockwell Park.
Sources: en.wikipedia.org
8 November – Votes for the 2026 Senedd election will be counted the day after election day rather than overnight after the polls close. Robert James and Sean Morgan, two former Labour council leaders, of Carmarthenshire and Caerphilly respectively, defect to the Green Party. 9 November – YouGov surveys have found that Andrew Mountbatten-Windsor (formerly known as Prince Andrew) has a 13% approval rating from the general public whilst the Starmer Government has a rating of 12%. 10 November – Northern Ireland Education Minister Paul Givan survives a vote of no confidence after a motion proposed by People Before Profit fails to gain cross-party support. 12 November – Starmer tells Prime Minister's Questions he has "never authorised" attacks on his cabinet ministers after his political allies within Labour told a number of media outlets he could face a leadership challenge from a prominent member of his cabinet. Reform UK says it will no longer co-operate with the making of a BBC documentary about the party following the controversy involving a Donald Trump speech. The Senedd Standards Commission recommends Laura Anne Jones, the Senedd's only Reform UK member, face a two-week suspension from the chamber for her use of a racial slur against Chinese people in a WhatsApp group in August 2023, while she was a member of the Welsh Conservatives. Andy Osborn, a Cambridgeshire County Council member, elected to represent Reform UK, is under investigation for describing children in care as "downright evil" at a council meeting in June.
== History == In 1932, Belgian physiologist Jean La Barre used the word "incretin" for a gut hormone which stimulates the endocrine pancreas including insulin release. He also proposed that such incretins could be used as a treatment for diabetes mellitus.
=== Sulfuric acid production === Oleum is an important intermediate in the manufacture of sulfuric acid due to its high enthalpy of hydration. When SO3 is added to water, rather than dissolving, it tends to form a fine mist of sulfuric acid, which is difficult to manage. However, SO3 added to concentrated sulfuric acid readily dissolves, forming oleum which can then be diluted with water to produce additional concentrated sulfuric acid. Typically, above concentrations of 98.3%, sulfuric acid will undergo a spontaneous decomposition into sulfur trioxide and water
== Physiology == A subunits of human factor XIII are made primarily by platelets and other cells of bone marrow origin. B subunits are secreted into blood by hepatocytes. A and B units combine within blood to form heterotetramers of two A units and two B units. Blood plasma concentration of the heterotetramers is 14–48 mg/L and half-life is 9–14 days. A clot that has not been stabilized by FXIIIa is soluble in 5 mol/L urea, while a stabilized clot is resistant to this phenomenon.
Bush was engaged to Cathryn Lee Wolfman in 1967, but the engagement did not last. Bush and Wolfman remained on good terms after the end of the relationship. While Bush was at a backyard barbecue in 1977, friends introduced him to Laura Welch, a schoolteacher and librarian. After a three-month courtship, she accepted his marriage proposal and they wed on November 5 of that year. The couple settled in Midland, Texas. Bush left his family's Episcopal Church to join his wife's United Methodist Church. On November 25, 1981, Laura Bush gave birth to fraternal twin daughters, Barbara and Jenna. Bush describes being challenged by Billy Graham to consider faith in Jesus "Christ as the risen Lord", how he began reading the Bible daily, "surrendering" to "the Almighty", that "faith is a walk" and that he was "moved by God's love".
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
Lyophilized AOD9604 is generally kept at -20 °C or colder, desiccated, and protected from light. Reconstituted solutions are usually refrigerated and handled to minimize repeated freeze-thaw cycles. These are general laboratory handling practices, not instructions for human use.